产品名称
Astec® CYCLOBOND I 2000 手性 HPLC 色谱柱, 5 μm particle size, L × I.D. 10 cm × 2.1 mm
material
stainless steel column
Quality Level
product line
Astec®
packaging
pkg of 1 ea
manufacturer/tradename
Astec®
parameter
0-50 °C temperature, 172 bar pressure (2500 psi)
technique(s)
HPLC: suitable, LC/MS: suitable
L × I.D.
10 cm × 2.1 mm
matrix
silica particle platform
matrix active group
cyclodextrin, beta- phase
particle size
5 μm
pore size
100 Å
operating pH
3.5-7
separation technique
chiral
General description
CYCLOBOND I 2000 通过一个有专利的工艺与 β-环糊精结合,生成稳定的基质,环糊精的排列方式使其保留了形成包合物的最有价值的性质。这允许它们通过选择性地将多种有机分子包括在其空腔中,来实现多种化学分离。对于各种分子类型,极性有机模式也可以进行非包含型分离。
资源:
CYCLOBOND 常见问题解答
CYCLOBOND参考文献
手性产品文献
- 结合阶段:未衍生化的、天然的 β-环糊精
资源:
CYCLOBOND 常见问题解答
CYCLOBOND参考文献
手性产品文献
Legal Information
Astec is a registered trademark of Merck KGaA, Darmstadt, Germany
Still not finding the right product?
Explore all of our products under Astec® CYCLOBOND I 2000 手性 HPLC 色谱柱
法规信息
新产品
此项目有
相关内容
CYCLOBOND is the name given to Astec technology for bonding cyclodextrins to a high purity silica gel through a stable ether linkage.
A F Casy et al.
Journal of pharmaceutical and biomedical analysis, 9(10-12), 787-792 (1991-01-01)
The interaction of beta-cyclodextrin with a series of structurally related chiral thromboxane antagonists was investigated using NMR and RP-HPLC. HPLC studies used both a cyclodextrin bonded phase (Cyclobond I), and beta-cyclodextrin as a mobile phase additive with an achiral C8
High-performance liquid chromatographic determination of ibuprofen, its metabolites and enantiomers in biological fluids
Geisslinger, G., et al.
Journal of Chromatography. B, Biomedical Sciences and Applications, 491, 139-149 (1989)
Chiral separations of ?-blocking drug substances using chiral stationary phases
Ekelund, Jens, et al.
Journal of Chromatography A, 708 (2), 253-261 (1995)
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| 20018AST | 04061833514184 |